Alcohol-abuse drug disulfiram targets cancer via p97 segregase adaptor NPL4

The central role of the propensity score in observational studies for causal effects

ROSENBAUM, P. R., & RUBIN, D. B. (1983) · Biometrika · doi:10.1093/biomet/70.1.41 · Cited by 31,241 · see citing works

Molecular Chaperone Functions in Protein Folding and Proteostasis

Kim, Y., Hipp, M. S., Bracher, A., Hayer-Hartl, M. K., & Hartl, F. U. (2013) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-060208-092442 · Cited by 1,468 · see citing works

Target identification using drug affinity responsive target stability (DARTS)

Lomenick, B., Hao, R., Jonai, N., Chin, R., Aghajan, M., Warburton, S., Wang, J., Wu, R. P., Gómez, F., Loo, J. A., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0910040106 · Cited by 1,113 · see citing works

Introduction to Danish (nationwide) registers on health and social issues: Structure, access, legislation, and archiving

Thygesen, L. C., Daasnes, C., Thaulow, I., & Brønnum‐Hansen, H. (2011) · Scandinavian Journal of Public Health · doi:10.1177/1403494811399956 · Cited by 1,089 · see citing works

Role of Rpn11 Metalloprotease in Deubiquitination and Degradation by the 26 S Proteasome

Verma, R., Aravind, L., Oania, R. S., McDonald, W. H., Yates, J. R., Koonin, E. V., & Deshaies, R. J. (2002) · Science · doi:10.1126/science.1075898 · Cited by 994 · see citing works

RNF168 Binds and Amplifies Ubiquitin Conjugates on Damaged Chromosomes to Allow Accumulation of Repair Proteins

Doil, C., Mailand, N., Bekker‐Jensen, S., Ménard, P., Larsen, D. H., Pepperkok, R., Ellenberg, J., Panier, S., Durocher, D., Bártek, J., et al. (2009) · Cell · doi:10.1016/j.cell.2008.12.041 · Cited by 938 · see citing works

Emerging functions of the VCP/p97 AAA-ATPase in the ubiquitin system

Meyer, H. H., Bug, M., & Bremer, S. (2012) · Nature Cell Biology · doi:10.1038/ncb2407 · Cited by 803 · see citing works

Disulfiram, a Clinically Used Anti-Alcoholism Drug and Copper-Binding Agent, Induces Apoptotic Cell Death in Breast Cancer Cultures and Xenografts via Inhibition of the Proteasome Activity

Chen, D., Cui, Q. C., Yang, H., & Dou, Q. P. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-2126 · Cited by 678 · see citing works

Therapeutic reduction of ataxin-2 extends lifespan and reduces pathology in TDP-43 mice

Becker, L. A., Huang, B., Bieri, G., Ma, R., Knowles, D. A., Jafar-Nejad, P., Messing, J., Kim, H. J., Soriano, A., Auburger, G., et al. (2017) · Nature · doi:10.1038/nature22038 · Cited by 571 · see citing works

Cell death assays for drug discovery

Kepp, O., Galluzzi, L., Lipinski, M. M., Yuan, J., & Kroemer, G. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3373 · Cited by 556 · see citing works

Valosin-containing protein is a multi-ubiquitin chain-targeting factor required in ubiquitin–proteasome degradation

Dai, R. M., & Li, C.-C. H. (2001) · Nature Cell Biology · doi:10.1038/35087056 · Cited by 437 · see citing works

Disulfiram modulated ROS–MAPK and NFκB pathways and targeted breast cancer cells with cancer stem cell-like properties

Yip, N. C., Fombon, I. S., Liu, P., Brown, S., Kannappan, V., Armesilla, A. L., Xu, B., Cassidy, J., Darling, J. L., & Wang, W. (2011) · British Journal of Cancer · doi:10.1038/bjc.2011.126 · Cited by 422 · see citing works

Targeting the AAA ATPase p97 as an Approach to Treat Cancer through Disruption of Protein Homeostasis

Anderson, D. J., Moigne, R. L., Djakovic, S. N., Kumar, B., Rice, J., Wong, S., Wang, J., Yao, B., Valle, E., Soly, S. K. V., et al. (2015) · Cancer Cell · doi:10.1016/j.ccell.2015.10.002 · Cited by 391 · see citing works

Covalent and allosteric inhibitors of the ATPase VCP/p97 induce cancer cell death

Magnaghi, P., D’Alessio, R., Valsasina, B., Avanzi, N. R., Rizzi, S., Asa, D., Gasparri, F., Cozzi, L., Cucchi, U., Orrenius, C., et al. (2013) · Nature Chemical Biology · doi:10.1038/nchembio.1313 · Cited by 369 · see citing works

A mechanism of ubiquitin-independent proteasomal degradation of the tumor suppressors p53 and p73

Asher, G., Tsvetkov, P., Kahana, C., & Shaul, Y. (2005) · Genes & Development · doi:10.1101/gad.319905 · Cited by 367 · see citing works

Monitoring Activity and Inhibition of 26S Proteasomes with Fluorogenic Peptide Substrates

Kisselev, A. F., & Goldberg, A. L. (2005) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(05)98030-0 · Cited by 343 · see citing works

Proteotoxic crisis, the ubiquitin-proteasome system, and cancer therapy

Deshaies, R. J. (2014) · BMC Biology · doi:10.1186/s12915-014-0094-0 · Cited by 334 · see citing works

Reversible inhibitor of p97, DBeQ, impairs both ubiquitin-dependent and autophagic protein clearance pathways

Chou, T., Brown, S. J., Minond, D., Nordin, B. E., Li, K., Jones, A. C., Chase, P. S., Porubsky, P. R., Stoltz, B. M., Schoenen, F. J., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1015312108 · Cited by 323 · see citing works

Regulation of p53 stability and p53-dependent apoptosis by NADH quinone oxidoreductase 1

Asher, G., Lotem, J., Cohen, B., Sachs, L., & Shaul, Y. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.98.3.1188 · Cited by 317 · see citing works

UBXD7 Binds Multiple Ubiquitin Ligases and Implicates p97 in HIF1α Turnover

Alexandru, G., Graumann, J., Smith, G. T., Kolawa, N. J., Fang, R., & Deshaies, R. J. (2008) · Cell · doi:10.1016/j.cell.2008.06.048 · Cited by 305 · see citing works

Repurposing drugs in oncology (ReDO)—Cimetidine as an anti-cancer agent

Pantziarka, P. (2014) · ecancermedicalscience · doi:10.3332/ecancer.2014.485 · Cited by 280 · see citing works

Methods for Monitoring Endoplasmic Reticulum Stress and the Unfolded Protein Response

Afshin Samali, A., FitzGerald, U., Deegan, S., & Gupta, S. (2010) · International Journal of Cell Biology · doi:10.1155/2010/830307 · Cited by 255 · see citing works

Disulfiram (DSF) acts as a copper ionophore to induce copper‐dependent oxidative stress and mediate anti‐tumor efficacy in inflammatory breast cancer

Allensworth, J. L., Evans, M. K., Bertucci, F., Aldrich, A. J., Festa, R. A., Finetti, P., Ueno, N. T., Safi, R., McDonnell, D. P., Thiele, D. J., et al. (2015) · Molecular Oncology · doi:10.1016/j.molonc.2015.02.007 · Cited by 243 · see citing works

High-Throughput Cell-Based Screening of 4910 Known Drugs and Drug-like Small Molecules Identifies Disulfiram as an Inhibitor of Prostate Cancer Cell Growth

Iljin, K., Ketola, K., Vainio, P., Halonen, P., Kohonen, P. J., Fey, V., Grafström, R. C., Perälä, M., & Kallioniemi, O. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-1035 · Cited by 242 · see citing works

HSF1: Guardian of Proteostasis in Cancer

Dai, C., & Sampson, S. B. (2015) · Trends in Cell Biology · doi:10.1016/j.tcb.2015.10.011 · Cited by 213 · see citing works

p97-dependent retrotranslocation and proteolytic processing govern formation of active Nrf1 upon proteasome inhibition

Radhakrishnan, S. K., den Besten, W., & Deshaies, R. J. (2014) · eLife · doi:10.7554/elife.01856 · Cited by 211 · see citing works

Ni(II), Cu(II), and Zn(II) Diethyldithiocarbamate Complexes Show Various Activities Against the Proteasome in Breast Cancer Cells

Cvek, B., Milacic, V., Taraba, J., & Dou, Q. P. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm8007807 · Cited by 208 · see citing works

A Phase IIb Trial Assessing the Addition of Disulfiram to Chemotherapy for the Treatment of Metastatic Non-Small Cell Lung Cancer

Nechushtan, H., Hamamreh, Y., Nidal, S., Gotfried, M., Baron, A., Shalev, Y. I., Nisman, B., Peretz, T., & Peylan‐Ramu, N. (2015) · The Oncologist · doi:10.1634/theoncologist.2014-0424 · Cited by 204 · see citing works

Copper Signaling Axis as a Target for Prostate Cancer Therapeutics

Safi, R., Nelson, E. R., Chitneni, S. K., Franz, K. J., George, D. J., Zalutsky, M. R., & McDonnell, D. P. (2014) · Cancer Research · doi:10.1158/0008-5472.can-13-3527 · Cited by 202 · see citing works

A Cellular System that Degrades Misfolded Proteins and Protects against Neurodegeneration

Guo, L., Giasson, B. I., Glavis-Bloom, A., Brewer, M. D., Shorter, J., Gitler, A. D., & Yang, X. (2014) · Molecular Cell · doi:10.1016/j.molcel.2014.04.030 · Cited by 192 · see citing works

ecancermedicalscience

Pantziarka, P., Bouche, G., Meheus, L., Sukhatme, V. V., Sukhatme, V. P., & Vikas, P. (2016) · ecancermedicalscience · doi:10.3332/ecancer.2014.442 · Cited by 173 · see citing works

Proteasome inhibitor-adapted myeloma cells are largely independent from proteasome activity and show complex proteomic changes, in particular in redox and energy metabolism

Soriano, G. P., Bešše, L., Li, N., Kraus, M., Bešše, A., Meeuwenoord, N. J., Bader, J. E., Everts, B., den Dulk, H., Overkleeft, H. S., et al. (2016) · Leukemia · doi:10.1038/leu.2016.102 · Cited by 142 · see citing works

Inhibition of proteasome activity, nuclear factor-KB translocation and cell survival by the antialcoholism drug disulfiram

Lövborg, H., Oberg, F. G., Rickardson, L., Gullbo, J., Nygren, P., & Larsson, R. L. (2005) · International Journal of Cancer · doi:10.1002/ijc.21534 · Cited by 127 · see citing works

Liposome encapsulated Disulfiram inhibits NFκB pathway and targets breast cancer stem cellsin vitroandin vivo

Liu, P., Wang, Z., Brown, S., Kannappan, V., Patricia, T. E., Jiang, W. G., Irache, J. M., Tang, J. Z., Britland, S. T., Armesilla, A. L., et al. (2014) · Oncotarget · doi:10.18632/oncotarget.2166 · Cited by 124 · see citing works

Nonprofit drugs as the salvation of the world's healthcare systems: the case of Antabuse (disulfiram)

Cvek, B. (2011) · Drug Discovery Today · doi:10.1016/j.drudis.2011.12.010 · Cited by 115 · see citing works

Elevated Expression of Valosin-Containing Protein (p97) Is Associated with Poor Prognosis of Prostate Cancer

Tsujimoto, Y., Tomita, Y., Hoshida, Y., Kono, T., Oka, T., Yamamoto, S., Nonomura, N., Okuyama, Ä., & Aozasa, K. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-03-0191 · Cited by 114 · see citing works

Alcohol drinking and all cancer mortality: a meta-analysis

Jin, M., Cai, S., Guo, J., Zhu, Y., Li, M., Yu, Y., Zhang, S., & Chen, K. (2012) · Annals of Oncology · doi:10.1093/annonc/mds508 · Cited by 113 · see citing works

Disulfiram targeting lymphoid malignant cell lines via ROS-JNK activation as well as Nrf2 and NF-kB pathway inhibition

Zha, J., Chen, F., Dong, H., Shi, P., Yao, Y., Zhang, Y., Li, R., Wang, S., Li, P., Wang, W., et al. (2014) · Journal of Translational Medicine · doi:10.1186/1479-5876-12-163 · Cited by 108 · see citing works

Mining for therapeutic gold

Collins, F. S. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3461 · Cited by 108 · see citing works

Copper improves the anti-angiogenic activity of disulfiram through the EGFR/Src/VEGF pathway in gliomas

Li, Y., Fu, S.-Y., Wang, L., Wang, F., Wang, N., Cao, Q., Wang, Y., Yang, J., & Wu, C. (2015) · Cancer Letters · doi:10.1016/j.canlet.2015.07.029 · Cited by 95 · see citing works

Expression of Valosin-Containing Protein in Colorectal Carcinomas as a Predictor for Disease Recurrence and Prognosis

Yamamoto, S., Tomita, Y., Hoshida, Y., Sakon, M., Kameyama, M., Imaoka, S., Sekimoto, M., Nakamori, S., Monden, M., & Aozasa, K. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-1576-03 · Cited by 88 · see citing works

Sodium ditiocarb as adjuvant immunotherapy for high risk breast cancer: A randomized study

Dufour, P., Lang, J.-M., Giron, C., Duclos, B., Haehnel, P., Jaeck, D., Jung, J. M., & Oberling, F. (1993) · Biotherapy · doi:10.1007/bf01877380 · Cited by 86 · see citing works

Targeting Malignancies with Disulfiram (Antabuse): Multidrug Resistance, Angiogenesis, and Proteasome

Cvek, B. (2011) · Current Cancer Drug Targets · doi:10.2174/156800911794519806 · Cited by 78 · see citing works

Quantitative Cell-based Protein Degradation Assays to Identify and Classify Drugs That Target the Ubiquitin-Proteasome System

Chou, T., & Deshaies, R. J. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.215319 · Cited by 64 · see citing works

The origin of an EPR signal observed in dithiocarbamate-loaded tissues

Suzuki, Y., Fujii, S., Teiji, T., Yoshimoto, T., Yoshimura, T., & Kamada, H. (1997) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/s0304-4165(97)00027-5 · Cited by 60 · see citing works

Determination of in vivo adducts of disulfiram with mitochondrial aldehyde dehydrogenase

Shen, M. L., Johnson, K. L., Mays, D. C., Lipsky, J. J., & Naylor, S. (2001) · Biochemical Pharmacology · doi:10.1016/s0006-2952(00)00586-4 · Cited by 57 · see citing works

Combined Inhibition of p97 and the Proteasome Causes Lethal Disruption of the Secretory Apparatus in Multiple Myeloma Cells

Auner, H. W., Moody, A. M., Ward, T. H., Kraus, M., Milan, E., May, P. C., Chaidos, A., Driessen, C., Cenci, S., Dazzi, F., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0074415 · Cited by 53 · see citing works

The p97-UFD1L-NPL4 Protein Complex Mediates Cytokine-Induced IκBα Proteolysis

Li, J.-M., Wu, H., Zhang, W., Blackburn, M. R., & Jin, J. (2013) · Molecular and Cellular Biology · doi:10.1128/mcb.01190-13 · Cited by 51 · see citing works

Biophysical Methods in Drug Discovery from Small Molecule to Pharmaceutical

Holdgate, G. A., Geschwindner, S., Breeze, A. L., Davies, G. M., Colclough, N., Temesi, D. G., & Ward, L. T. (2013) · Methods in molecular biology · doi:10.1007/978-1-62703-398-5_12 · Cited by 46 · see citing works

Purification of proteins containing zinc finger domains using immobilized metal ion affinity chromatography

Voráčková, I., Suchanová, Š., Ulbrich, P., Diehl, W. E., & Ruml, T. (2011) · Protein Expression and Purification · doi:10.1016/j.pep.2011.04.022 · Cited by 36 · see citing works

High expression of valosin-containing protein predicts poor prognosis in patients with breast carcinoma

Cui, Y., Niu, M., Zhang, X., Zhong, Z., Wang, J., & Pang, D. (2015) · Tumor Biology · doi:10.1007/s13277-015-3748-9 · Cited by 18 · see citing works

The p97-Ufd1-Npl4 ATPase complex ensures robustness of the G2/M checkpoint by facilitating CDC25A degradation

Riemer, A., Dobrynin, G., Dressler, A., Bremer, S., Soni, A., Iliakis, G. E., & Meyer, H. H. (2014) · Cell Cycle · doi:10.4161/cc.27779 · Cited by 17 · see citing works

Analysis of Npl4 deletion mutants in mammalian cells unravels new Ufd1-interacting motifs and suggests a regulatory role of Npl4 in ERAD

Lass, A., McConnell, E. J., Fleck, K., Palamarchuk, A., & Wójcik, C. (2008) · Experimental Cell Research · doi:10.1016/j.yexcr.2008.06.008 · Cited by 16 · see citing works

Copper induces cell death by targeting lipoylated TCA cycle proteins

Tsvetkov, P., Coy, S., Petrova, B., Dreishpoon, M., Verma, A., Abdusamad, M., Rossen, J., Joesch-Cohen, L., Humeidi, R., Spangler, R. D., et al. (2022) · Science · doi:10.1126/science.abf0529 · Cited by 4,932 · see citing works

Reactive Oxygen Species (ROS)-Based Nanomedicine

Yang, B., Chen, Y., & Shi, J. (2019) · Chemical Reviews · doi:10.1021/acs.chemrev.8b00626 · Cited by 2,453 · see citing works

Connecting copper and cancer: from transition metal signalling to metalloplasia

Ge, E. J., Bush, A. I., Casini, A., Cobine, P. A., Cross, J. R., DeNicola, G. M., Dou, Q. P., Franz, K. J., Gohil, V. M., Gupta, S. K., et al. (2021) · Nature reviews. Cancer · doi:10.1038/s41568-021-00417-2 · Cited by 1,316 · see citing works

FDA-approved disulfiram inhibits pyroptosis by blocking gasdermin D pore formation

Hu, J. J., Liu, X., Xia, S., Zhang, Z., Zhang, Y., Zhao, J., Ruan, J., Luo, X., Lou, X., Bai, Y., et al. (2020) · Nature Immunology · doi:10.1038/s41590-020-0669-6 · Cited by 1,145 · see citing works

mTOR signalling and cellular metabolism are mutual determinants in cancer

Mossmann, D., Park, S., & Hall, M. N. (2018) · Nature reviews. Cancer · doi:10.1038/s41568-018-0074-8 · Cited by 1,088 · see citing works

Discovering the anticancer potential of non-oncology drugs by systematic viability profiling

Corsello, S. M., Nagari, R. T., Spangler, R. D., Rossen, J., Kocak, M., Bryan, J. G., Humeidi, R., Peck, D., Wu, X., Tang, A. A., et al. (2020) · Nature Cancer · doi:10.1038/s43018-019-0018-6 · Cited by 878 · see citing works

Cuproptosis: mechanisms and links with cancers

Xie, J., Yang, Y., Gao, Y., & He, J. (2023) · Molecular Cancer · doi:10.1186/s12943-023-01732-y · Cited by 831 · see citing works

Channelling inflammation: gasdermins in physiology and disease

Liu, X., Xia, S., Zhang, Z., Wu, H., & Lieberman, J. (2021) · Nature Reviews Drug Discovery · doi:10.1038/s41573-021-00154-z · Cited by 756 · see citing works

Copper metabolism in cell death and autophagy

Xue, Q., Kang, R., Klionsky, D. J., Tang, D., Liu, J., & Chen, X. (2023) · Autophagy · doi:10.1080/15548627.2023.2200554 · Cited by 720 · see citing works

Gasdermin D in pyroptosis

Burdette, B. E., Esparza, A. N., Zhu, H., & Wang, S. (2021) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2021.02.006 · Cited by 710 · see citing works

Overcoming cancer therapeutic bottleneck by drug repurposing

Zhang, Z., Zhou, L., Xie, N., Nice, E. C., Zhang, T., Cui, Y., & Huang, C. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-00213-8 · Cited by 521 · see citing works

Targeting cuproplasia and cuproptosis in cancer

Tang, D., Kroemer, G., & Kang, R. (2024) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-024-00876-0 · Cited by 475 · see citing works

Drug repurposing for cancer therapy

Xia, Y., Sun, M., Huang, H., & Jin, W.-L. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01808-1 · Cited by 443 · see citing works

Selective Targeting of Cancer Cells by Copper Ionophores: An Overview

Oliveri, V. (2022) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2022.841814 · Cited by 368 · see citing works

Enhanced Tumor-Specific Disulfiram Chemotherapy by In Situ Cu 2+ Chelation-Initiated Nontoxicity-to-Toxicity Transition

Wu, W., Yu, L., Jiang, Q., Huo, M., Lin, H., Wang, L., Chen, Y., & Shi, J. (2019) · Journal of the American Chemical Society · doi:10.1021/jacs.9b03503 · Cited by 359 · see citing works

Overcoming the compensatory elevation of NRF2 renders hepatocellular carcinoma cells more vulnerable to disulfiram/copper-induced ferroptosis

Ren, X., Li, Y., Zhou, Y., Hu, W., Yang, C., Jing, Q., Zhou, C., Wang, X., Hu, J., Wang, L., et al. (2021) · Redox Biology · doi:10.1016/j.redox.2021.102122 · Cited by 313 · see citing works

A hybrid injectable hydrogel from hyperbranched PEG macromer as a stem cell delivery and retention platform for diabetic wound healing

Xu, Q., Sigen, A., Gao, Y., Guo, L., Creagh-Flynn, J., Zhou, D., Greiser, U., Dong, Y., Wang, F., Tai, H., et al. (2018) · Acta Biomaterialia · doi:10.1016/j.actbio.2018.05.039 · Cited by 300 · see citing works

Cuproptosis: A novel therapeutic target for overcoming cancer drug resistance

Wang, Y., Chen, Y., Zhang, J., Yang, Y., Fleishman, J. S., Wang, Y., Wang, J., Chen, J., Li, Y., & Wang, H. (2023) · Drug Resistance Updates · doi:10.1016/j.drup.2023.101018 · Cited by 265 · see citing works

Dual-targeting biomimetic delivery for anti-glioma activity via remodeling the tumor microenvironment and directing macrophage-mediated immunotherapy

Zhao, P., Wang, Y., Kang, X., Wu, A., Yin, W., Tang, Y., Wang, J., Zhang, M., Duan, Y., & Huang, Y. (2018) · Chemical Science · doi:10.1039/c7sc04853j · Cited by 249 · see citing works

Cystathionine-β-synthase: Molecular Regulation and Pharmacological Inhibition

Zuhra, K., Augsburger, F., Majtán, T., & Szabó, C. (2020) · Biomolecules · doi:10.3390/biom10050697 · Cited by 244 · see citing works

Photothermally Triggered Copper Payload Release for Cuproptosis‐Promoted Cancer Synergistic Therapy

Zhou, J., Yu, Q., Song, J., Li, S., Li, X., Kang, B., Chen, H., & Xu, J. (2022) · Angewandte Chemie International Edition · doi:10.1002/anie.202213922 · Cited by 240 · see citing works

Copper-based metal–organic frameworks for biomedical applications

Cun, J., Xi, F., Pan, Q., Gao, W., Luo, K., He, B., & Pu, Y. (2022) · Advances in Colloid and Interface Science · doi:10.1016/j.cis.2022.102686 · Cited by 237 · see citing works

Engineering Antimicrobial Metal–Phenolic Network Nanoparticles with High Biocompatibility for Wound Healing

Yu, R., Chen, H., He, J., Zhang, Z., Zhou, J., Zheng, Q., Fu, Z., Lu, C., Lin, Z., Caruso, F., et al. (2023) · Advanced Materials · doi:10.1002/adma.202307680 · Cited by 223 · see citing works

Copper‐Enriched Prussian Blue Nanomedicine for In Situ Disulfiram Toxification and Photothermal Antitumor Amplification

Wu, W., Yu, L., Pu, Y., Yao, H., Chen, Y., & Shi, J. (2020) · Advanced Materials · doi:10.1002/adma.202000542 · Cited by 216 · see citing works

Epigenetic modulations and lineage plasticity in advanced prostate cancer

Ge, R., Wang, Z., Montironi, R., Jiang, Z., Cheng, M., Santoni, M., Huang, K., Massari, F., Lü, X., Cimadamore, A., et al. (2020) · Annals of Oncology · doi:10.1016/j.annonc.2020.02.002 · Cited by 213 · see citing works

The molecular mechanisms of cuproptosis and its relevance to cardiovascular disease

Wang, D., Tian, Z., Zhang, P., Zhen, L., Meng, Q., Sun, B., Xu, X.-L., Jia, T., & Li, S. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.114830 · Cited by 206 · see citing works

Mammalian copper homeostasis: physiological roles and molecular mechanisms

Lutsenko, S., Roy, S., & Tsvetkov, P. (2024) · Physiological Reviews · doi:10.1152/physrev.00011.2024 · Cited by 206 · see citing works

The molecular mechanism and therapeutic landscape of copper and cuproptosis in cancer

Guo, Z., Chen, D., Yao, L., Sun, Y., Li, D., Le, J., Dian, Y., Zeng, F., Chen, X., & Deng, G. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02192-0 · Cited by 201 · see citing works

Cuproptosis: Harnessing Transition Metal for Cancer Therapy

Wang, W., Mo, W., Hang, Z.-S., Huang, Y., Yi, H., Sun, Z., & Lei, A. (2023) · ACS Nano · doi:10.1021/acsnano.3c07775 · Cited by 199 · see citing works

Disulfiram/Copper Induces Antitumor Activity against Both Nasopharyngeal Cancer Cells and Cancer-Associated Fibroblasts through ROS/MAPK and Ferroptosis Pathways

Li, Y., Chen, F., Chen, J., Chan, S., He, Y., Liu, W., & Zhang, G. (2020) · Cancers · doi:10.3390/cancers12010138 · Cited by 191 · see citing works

Modulation of Intracellular Copper Levels as the Mechanism of Action of Anticancer Copper Complexes: Clinical Relevance

Babak, M. V., & Ahn, D. (2021) · Biomedicines · doi:10.3390/biomedicines9080852 · Cited by 186 · see citing works

The combination of disulfiram and copper for cancer treatment

Li, H., Wang, J., Wu, C., Wang, L., Chen, Z.-S., & Cui, W. (2020) · Drug Discovery Today · doi:10.1016/j.drudis.2020.04.003 · Cited by 185 · see citing works

Drug repurposing in oncology: Compounds, pathways, phenotypes and computational approaches for colorectal cancer

Nowak-Sliwinska, P. M., Scapozza, L., & Altaba, A. R. I. (2019) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2019.04.005 · Cited by 183 · see citing works

Biomedical applications of copper ionophores

Oliveri, V. (2020) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2020.213474 · Cited by 171 · see citing works

Advanced Development of Primary Pancreatic Organoid Tumor Models for High-Throughput Phenotypic Drug Screening

Hou, S., Tiriac, H., Sridharan, B. P., Scampavia, L. D., Madoux, F., Seldin, J., Souza, G. R., Watson, D., Tuveson, D. A., & Spicer, T. (2018) · SLAS DISCOVERY · doi:10.1177/2472555218766842 · Cited by 168 · see citing works

The ubiquitin-dependent ATPase p97 removes cytotoxic trapped PARP1 from chromatin

Krastev, D. B., Li, S., Sun, Y., Wicks, A. J., Hoslett, G., Weekes, D. B., Badder, L. M., Knight, E. G., Marlow, R., Pardo, M., et al. (2022) · Nature Cell Biology · doi:10.1038/s41556-021-00807-6 · Cited by 163 · see citing works

State-of-the-art advances of copper-based nanostructures in the enhancement of chemodynamic therapy

Hao, Y., Zhang, W., Gao, Y., Wei, Y., Shu, Y., & Wang, J. (2020) · Journal of Materials Chemistry B · doi:10.1039/d0tb02360d · Cited by 162 · see citing works

Disulfiram: a novel repurposed drug for cancer therapy

Chen, L., Li, X., Ren, Y., & Zhang, X. (2021) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-020-04216-8 · Cited by 159 · see citing works

Disulfiram Copper Nanoparticles Prepared with a Stabilized Metal Ion Ligand Complex Method for Treating Drug-Resistant Prostate Cancers

Chen, W., Yang, W. L., Chen, P., Huang, Y., & Li, F. (2018) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.8b14940 · Cited by 155 · see citing works

The role of ALDH2 in tumorigenesis and tumor progression: Targeting ALDH2 as a potential cancer treatment

Zhang, H., & Fu, L. (2021) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2021.02.008 · Cited by 153 · see citing works

Reversal of cisplatin chemotherapy resistance by glutathione-resistant copper-based nanomedicine via cuproptosis

Lu, Y., Pan, Q., Gao, W., Pu, Y., & He, B. (2022) · Journal of Materials Chemistry B · doi:10.1039/d2tb01150f · Cited by 152 · see citing works

Targeting cuproptosis for cancer therapy: mechanistic insights and clinical perspectives

Zhang, C., Huang, T., & Li, L. (2024) · Journal of Hematology & Oncology · doi:10.1186/s13045-024-01589-8 · Cited by 152 · see citing works

Leveraging disulfiram to treat cancer: Mechanisms of action, delivery strategies, and treatment regimens

Lu, Y., Pan, Q., Gao, W., Pu, Y., Luo, K., He, B., & Gu, Z. (2022) · Biomaterials · doi:10.1016/j.biomaterials.2021.121335 · Cited by 149 · see citing works

Cope with copper: From copper linked mechanisms to copper-based clinical cancer therapies

Wang, X., Zhou, M., Liu, Y., & Si, Z. (2023) · Cancer Letters · doi:10.1016/j.canlet.2023.216157 · Cited by 147 · see citing works

Recent Advances in Repurposing Disulfiram and Disulfiram Derivatives as Copper-Dependent Anticancer Agents

Kannappan, V., Ali, M., Small, B., Rajendran, G., Elzhenni, S., Taj, H., Wang, W., & Dou, Q. P. (2021) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2021.741316 · Cited by 134 · see citing works

Remodeling tumor immune microenvironment (TIME) for glioma therapy using multi-targeting liposomal codelivery

Zheng, Z., Zhang, J., Jiang, J., He, Y., Zhang, W., Mo, X., Kang, X., Xu, Q., Wang, B., & Huang, Y. (2020) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2019-000207 · Cited by 132 · see citing works

Drug tolerant persister cell plasticity in cancer: a revolutionary strategy for more effective anticancer therapies

He, J., Qiu, Z., Fan, J., Xie, X., Sheng, Q., & Sui, X. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01891-4 · Cited by 132 · see citing works

Exploration of databases and methods supporting drug repurposing: a comprehensive survey

Tanoli, Z., Seemab, U., Scherer, A., Wennerberg, K., Tang, J., & Vähä-Koskela, M. (2021) · Briefings in Bioinformatics · doi:10.1093/bib/bbaa003 · Cited by 131 · see citing works

Scintillator-Based Nanohybrids with Sacrificial Electron Prodrug for Enhanced X-ray-Induced Photodynamic Therapy

Wang, H., Lv, B., Tang, Z., Zhang, M., Ge, W., Liu, Y., He, X., Zhao, K., Zheng, X., He, M., et al. (2018) · Nano Letters · doi:10.1021/acs.nanolett.8b02409 · Cited by 130 · see citing works

Disulfiram inhibits neutrophil extracellular trap formation and protects rodents from acute lung injury and SARS-CoV-2 infection

Adrover, J. M., Carrau, L., Daßler‐Plenker, J., Bram, Y., Chandar, V., Houghton, S., Redmond, D., Merrill, J. R., Shevik, M. E., tenOever, B. R., et al. (2022) · JCI Insight · doi:10.1172/jci.insight.157342 · Cited by 128 · see citing works

Disulfiram: Mechanisms, Applications, and Challenges

Lanz, J., Biniaz-Harris, N., Kuvaldina, M., Jain, S., Lewis, K., & Fallon, B. A. (2023) · Antibiotics · doi:10.3390/antibiotics12030524 · Cited by 125 · see citing works

Inhibiting the compensatory elevation of xCT collaborates with disulfiram/copper-induced GSH consumption for cascade ferroptosis and cuproptosis

Zhang, P., Zhou, C., Ren, X., Jing, Q., Gao, Y., Yang, C., Shen, Y., Zhou, Y., Hu, W., Jin, F., et al. (2023) · Redox Biology · doi:10.1016/j.redox.2023.103007 · Cited by 123 · see citing works

Computer-aided drug repurposing for cancer therapy: Approaches and opportunities to challenge anticancer targets

Mottini, C., Napolitano, F., Li, Z., Gao, X., & Cardone, L. (2019) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2019.09.023 · Cited by 122 · see citing works

Glioblastoma: Current Status, Emerging Targets, and Recent Advances

Thakur, A., Faujdar, C., Sharma, R., Sharma, S., Malik, B., Nepali, K., & Liou, J. (2022) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.1c01946 · Cited by 120 · see citing works

Repurposing Disulfiram as An Anti-Cancer Agent: Updated Review on Literature and Patents

Ekinci, E., Rohondia, S. O., Khan, R., & Dou, Q. P. (2019) · Recent Patents on Anti-Cancer Drug Discovery · doi:10.2174/1574892814666190514104035 · Cited by 119 · see citing works

Copper in cancer: From pathogenesis to therapy

Guan, D., Zhao, L., Shi, X., Ma, X., & Chen, Z. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.114791 · Cited by 118 · see citing works

Recent Progress in the Drug Development Targeting SARS-CoV-2 Main Protease as Treatment for COVID-19

Cui, W., Yang, K., & Yang, H. (2020) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2020.616341 · Cited by 117 · see citing works

Tumor Microenvironment Responsive Hollow Nanoplatform for Triple Amplification of Oxidative Stress to Enhance Cuproptosis‐Based Synergistic Cancer Therapy

Xu, W., Wang, Y., Hou, G., Wang, J., Wang, T., Qian, J., & Suo, A. (2023) · Advanced Healthcare Materials · doi:10.1002/adhm.202202949 · Cited by 116 · see citing works

Protein lipoylation: mitochondria, cuproptosis, and beyond

Lin, C.-H., Chin, Y., Zhou, M., Sobol, R. W., Hung, M., & Tan, M. (2024) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2024.04.002 · Cited by 116 · see citing works

Disulfiram’s anti-cancer activity reflects targeting NPL4, not inhibition of aldehyde dehydrogenase

Skrott, Z., Majera, D., Gursky, J., Buchtova, T., Hajduch, M., Mistrik, M., & Bartek, J. (2019) · Oncogene · doi:10.1038/s41388-019-0915-2 · Cited by 115 · see citing works

Drug Repositioning in Glioblastoma: A Pathway Perspective

Tan, S. K., Jermakowicz, A. M., Mookhtiar, A. K., Nemeroff, C. B., Schürer, S. C., & Ayad, N. G. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00218 · Cited by 115 · see citing works

Neuroendocrine Differentiation of Prostate Cancer—An Intriguing Example of Tumor Evolution at Play

Patel, G. K., Chugh, N., & Tripathi, M. (2019) · Cancers · doi:10.3390/cancers11101405 · Cited by 114 · see citing works

Copper in cancer: from limiting nutrient to therapeutic target

Tang, X., Yan, Z., Miao, Y., Ha, W., Li, Z., Yang, L., & Mi, D. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1209156 · Cited by 114 · see citing works

Drug Repositioning for Effective Prostate Cancer Treatment

Turanlı, B., Grøtli, M., Borén, J., Nielsen, J., Uhlén, M., Arğa, K. Y., & Mardinoğlu, A. (2018) · Frontiers in Physiology · doi:10.3389/fphys.2018.00500 · Cited by 109 · see citing works

Seesaw conformations of Npl4 in the human p97 complex and the inhibitory mechanism of a disulfiram derivative

Pan, M., Zheng, Q., Yu, Y., Ai, H., Xie, Y., Zeng, X., Wang, C., Liu, L., & Zhao, M. (2021) · Nature Communications · doi:10.1038/s41467-020-20359-x · Cited by 108 · see citing works

Highly Stable, Coordinated Polymeric Nanoparticles Loading Copper(II) Diethyldithiocarbamate for Combinational Chemo/Chemodynamic Therapy of Cancer

Peng, X., Pan, Q., Zhang, B., Wan, S., Li, S., Luo, K., Pu, Y., & He, B. (2019) · Biomacromolecules · doi:10.1021/acs.biomac.9b00367 · Cited by 107 · see citing works

Emerging Opportunities To Manipulate Metal Trafficking for Therapeutic Benefit

Hunsaker, E. W., & Franz, K. J. (2019) · Inorganic Chemistry · doi:10.1021/acs.inorgchem.9b01029 · Cited by 106 · see citing works

Old wine in new bottles: Advanced drug delivery systems for disulfiram-based cancer therapy

McMahon, A., Chen, W., & Li, F. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.01.001 · Cited by 105 · see citing works

Disulfiram suppresses NLRP3 inflammasome activation to treat peritoneal and gouty inflammation

Deng, W., Yang, Z., Hu, Y., Ou, Y., Hu, W., & Sun, P. (2020) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2020.03.007 · Cited by 105 · see citing works

Structure, Dynamics and Function of the 26S Proteasome

Mao, Y. (2020) · Sub-cellular biochemistry/Subcellular biochemistry · doi:10.1007/978-3-030-58971-4_1 · Cited by 105 · see citing works

Disulfiram ameliorates nonalcoholic steatohepatitis by modulating the gut microbiota and bile acid metabolism

Lei, Y., Tang, L., Chen, Q., Wu, L., He, W., Tu, D., Wang, S., Chen, Y., Liu, S., Xie, Z., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-34671-1 · Cited by 104 · see citing works

Phthalimide-Carried Disulfur Transfer To Synthesize Unsymmetrical Disulfanes via Copper Catalysis

Zou, J.-X., Chen, J., Shi, T., Hou, Y., Cao, F., Wang, Y., Wang, X., Jia, Z., Zhao, Q., & Wang, Z. (2019) · ACS Catalysis · doi:10.1021/acscatal.9b04326 · Cited by 102 · see citing works

Targeting FROUNT with Disulfiram Regulates Macrophage Responses in Cancer

Terashima, Y., Toda, E., Itakura, M., Otsuji, M., Yoshinaga, S., Okumura, K., Shand, F. H. W., Komohara, Y., Takeda, M., Kokubo, K., et al. (2018) · Nature Communications · doi:10.1038/s41467-020-14338-5 · Cited by 102 · see citing works

Cuproptosis: mechanisms and nanotherapeutic strategies in cancer and beyond

Mao, L., Lu, J., Wen, X., Song, Z., Sun, C., Zhao, Y., Huang, F., Chen, S., Jiang, D., Che, W., et al. (2025) · Chemical Society Reviews · doi:10.1039/d5cs00083a · Cited by 102 · see citing works

Structure of the Cdc48 ATPase with its ubiquitin-binding cofactor Ufd1–Npl4

Bodnar, N. O., Kim, K. H., Ji, Z., Wales, T. E., Svetlov, V. V., Nudler, E., Engen, J. R., Walz, T., & Rapoport, T. A. (2018) · Nature Structural & Molecular Biology · doi:10.1038/s41594-018-0085-x · Cited by 101 · see citing works

The copper age in cancer treatment: From copper metabolism to cuproptosis

Xie, W., Guo, Z., Zhao, L., & Wei, Y. (2023) · Progress in Materials Science · doi:10.1016/j.pmatsci.2023.101145 · Cited by 101 · see citing works

An insight into medicinal attributes of dithiocarbamates: Bird’s eye view

Shinde, S. D., Sakla, A. P., & Shankaraiah, N. (2020) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2020.104346 · Cited by 100 · see citing works

Nanomedicine Enables Drug-Potency Activation with Tumor Sensitivity and Hyperthermia Synergy in the Second Near-Infrared Biowindow

Liu, W., Xiang, H., Tan, M., Chen, Q., Jiang, Q., Yang, L., Cao, Y., Wang, Z., Ran, H., & Chen, Y. (2021) · ACS Nano · doi:10.1021/acsnano.0c08848 · Cited by 99 · see citing works

The revival of dithiocarbamates: from pesticides to innovative medical treatments

Kaul, L., Süss, R., Zannettino, A. C. W., & Richter, K. (2021) · iScience · doi:10.1016/j.isci.2021.102092 · Cited by 98 · see citing works

Catalytic chemistry of iron-free Fenton nanocatalysts for versatile radical nanotherapeutics

Chen, Q., Yang, D., Yu, L., Jing, X., & Chen, Y. (2019) · Materials Horizons · doi:10.1039/c9mh01565e · Cited by 95 · see citing works

Turning liabilities into opportunities: Off-target based drug repurposing in cancer

Palve, V. C., Liao, Y., Rix, L. L. R., & Rix, U. (2020) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2020.02.003 · Cited by 92 · see citing works

New drugs are not enough‑drug repositioning in oncology: An update

Armando, R., Mengual G�mez, D., & Gomez, D. (2020) · International Journal of Oncology · doi:10.3892/ijo.2020.4966 · Cited by 90 · see citing works

A dithiocarbamate-based H 2 O 2 -responsive prodrug for combinational chemotherapy and oxidative stress amplification therapy

Pan, Q., Zhang, B., Peng, X., Wan, S., Luo, K., Gao, W., Pu, Y., & He, B. (2019) · Chemical Communications · doi:10.1039/c9cc05438c · Cited by 90 · see citing works

Disulfiram loaded calcium phosphate nanoparticles for enhanced cancer immunotherapy

Li, Q., Chao, Y., Liu, B., Xiao, Z., Yang, Z., Wu, Y., & Liu, Z. (2022) · Biomaterials · doi:10.1016/j.biomaterials.2022.121880 · Cited by 90 · see citing works

Delivering metal ions by nanomaterials: Turning metal ions into drug-like cancer theranostic agents

Liu, C., Guo, L., Wang, Y., Zhang, J., & Fu, C. (2023) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2023.215332 · Cited by 90 · see citing works

Mechanistic insight into substrate processing and allosteric inhibition of human p97

Pan, M., Yu, Y., Ai, H., Zheng, Q., Xie, Y., Liu, L., & Zhao, M. (2021) · Nature Structural & Molecular Biology · doi:10.1038/s41594-021-00617-2 · Cited by 89 · see citing works

The Regulation and Modification of GSDMD Signaling in Diseases

Li, Z., Ji, S., Jiang, M., Xu, Y., & Zhang, C. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.893912 · Cited by 89 · see citing works

Cuproptosis: unveiling a new frontier in cancer biology and therapeutics

Feng, Y., Yang, Z., Wang, J., & Hai, Z. (2024) · Cell Communication and Signaling · doi:10.1186/s12964-024-01625-7 · Cited by 86 · see citing works

A cuproptosis-based nanomedicine suppresses triple negative breast cancers by regulating tumor microenvironment and eliminating cancer stem cells

Xiao, C., Wang, X., Li, S., Zhang, Z., Li, J., Deng, Q., Chen, X., Yang, X., & Li, Z. (2024) · Biomaterials · doi:10.1016/j.biomaterials.2024.122763 · Cited by 86 · see citing works

Targeting Ribosome Biogenesis in Cancer: Lessons Learned and Way Forward

Zisi, A., Bártek, J., & Lindström, M. S. (2022) · Cancers · doi:10.3390/cancers14092126 · Cited by 80 · see citing works

Aldehyde dehydrogenase in solid tumors and other diseases: Potential biomarkers and therapeutic targets

Xia, J. L., Li, S., Liu, S., & Zhang, L. (2023) · MedComm · doi:10.1002/mco2.195 · Cited by 80 · see citing works

Involvement of inflammasomes in tumor microenvironment and tumor therapies

Zhang, Z., Li, X., Wang, Y., Wei, Y., & Wei, X. (2023) · Journal of Hematology & Oncology · doi:10.1186/s13045-023-01407-7 · Cited by 79 · see citing works

Suppressing autophagy enhances disulfiram/copper-induced apoptosis in non-small cell lung cancer

Wu, X., Xue, X., Wang, L., Wang, W., Han, J., Sun, X., Zhang, H., Liu, Y., Che, X., Yang, J., et al. (2018) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2018.02.039 · Cited by 78 · see citing works

K29-linked ubiquitin signaling regulates proteotoxic stress response and cell cycle

Yu, Y., Zheng, Q., Erramilli, S. K., Pan, M., Park, S.-J., Xie, Y., Li, J., Fei, J., Kossiakoff, A. A., Liu, L., et al. (2021) · Nature Chemical Biology · doi:10.1038/s41589-021-00823-5 · Cited by 78 · see citing works

Disulfiram/Copper Induces Immunogenic Cell Death and Enhances CD47 Blockade in Hepatocellular Carcinoma

Gao, X., Huang, H., Pan, C., Mei, Z., Yin, S., Zhou, L., & Zheng, S. (2022) · Cancers · doi:10.3390/cancers14194715 · Cited by 78 · see citing works

Disulfiram combined with copper induces immunosuppression via PD-L1 stabilization in hepatocellular carcinoma.

Zhou, B., Guo, L., Zhang, B., Liu, S., Zhang, K., Yan, J., Zhang, W., Yu, M., Chen, Z., Xu, Y., et al. (2019) · PubMed Central · Cited by 77 · see citing works

Inhibitors of the ATPase p97/VCP: From basic research to clinical applications

Kilgas, S., & Ramadan, K. (2023) · Cell chemical biology · doi:10.1016/j.chembiol.2022.12.007 · Cited by 78 · see citing works

Synthesis, Characterization, and Biological Activity of Hybrid Thiosemicarbazone–Alkylthiocarbamate Metal Complexes

Andres, S. A., Bajaj, K., Vishnosky, N. S., Peterson, M. A., Mashuta, M. S., Buchanan, R. M., Bates, P. J., & Grapperhaus, C. A. (2020) · Inorganic Chemistry · doi:10.1021/acs.inorgchem.0c00182 · Cited by 75 · see citing works

Dysregulated Ribosome Biogenesis Reveals Therapeutic Liabilities in Cancer

Bursać, S., Prodan, Y., Pullen, N., Bártek, J., & Volarević, S. (2020) · Trends in cancer · doi:10.1016/j.trecan.2020.08.003 · Cited by 74 · see citing works

Nose-to-brain delivery of disulfiram nanoemulsion in situ gel formulation for glioblastoma targeting therapy

Qu, Y., Li, A., Ma, L., Iqbal, S., Sun, X., Ma, W., Li, C., Zheng, D., Xu, Z., Zhao, Z., et al. (2021) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2021.120250 · Cited by 74 · see citing works

Abstract LB-264: Alcohol-aversion drug disulfiram targets cancer via p97 segregase adaptor NPL4

Mistrík, M., Škrott, Z., Hajdúch, M., Friis, S., Džubák, P., Gurský, J., Majera, D., Oždian, T., Václavková, J., Michalova, M., et al. (2018) · Cancer Research · doi:10.1158/1538-7445.am2018-lb-264

The Alcohol-Abuse Drug Disulfiram Targets NPL4 to Exert Antitumor Effects

(2017) · Cancer Discovery · doi:10.1158/2159-8290.cd-rw2017-235 · Cited by 3 · see citing works

Anticancer effects of alcohol abuse drug

Crunkhorn, S. (2018) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2018.10

There must be another way—disulfiram and cancer treatment: editorial on “Alcohol-abuse drug disulfiram targets cancer via p97 segregase adaptor NPL4”

Nechushtan, H., & Peretz, T. (2018) · Translational Cancer Research · doi:10.21037/tcr.2018.03.34 · Cited by 1 · see citing works

Disulfiram combats cancer via crippling valosin-containing protein/p97 segregase adaptor NPL4

Ding, N., & Zhu, Q. (2018) · Translational Cancer Research · doi:10.21037/tcr.2018.03.33 · Cited by 11 · see citing works